Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(8):557–558. doi: 10.1002/clc.4960230803

Assessing ventricular function

C Richard Conti
PMCID: PMC6654859  PMID: 10941539

Full Text

The Full Text of this article is available as a PDF (227.2 KB).

References

  • 1. Global Utilization of Streptokinase and t‐PA for Occluded coronary arteries (GUSTO) Investigators: The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615–1622 [DOI] [PubMed] [Google Scholar]
  • 2. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G The Ad Hoc working group of the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI)‐2 Data Base: Determinants of 6‐month mortality in survivors of myocardial infarction after thrombolysis/Results of the GISSI‐2 data base. Circulation 1993; 88: 416–429 [DOI] [PubMed] [Google Scholar]
  • 3. Carluccio E, Tommasi S, Bentivoglio M, Buccolieri M, Prosciutti L, Corea L: Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy. Am J Cardiol 2000; 85: 411–415 [DOI] [PubMed] [Google Scholar]
  • 4. Pryor DB, Harrell FE Jr, Lee KL, Rosari RA, Coleman RE, Cobb FR, Califf RM, Jones RH: Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984; 53: 18–22 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES